| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
kinase suppressor of ras 2 | 0.743 | 0.231 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
phospholipase C like 1 (inactive) | 0.608 | 0.654 | 1.2E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
integrin subunit alpha 1 | 0.644 | 0.654 | 2.6E-16 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2016 | ||||||||
|
shortage in chiasmata 1 | 0.780 | 0.385 | 3.7E-22 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
potassium voltage-gated channel subfamily A member regulatory beta subunit 1 | 0.821 | 0.115 | 4.2E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
doublecortin like kinase 2 | 0.931 | 0.077 | 0.96 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
POM121 transmembrane nucleoporin like 9, pseudogene | 0.931 | 0.077 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2015 | 2017 | |||||||||
|
gamma-glutamyl carboxylase | 0.678 | 0.538 | 2.0E-14 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2015 | 2017 | ||||||||
|
BCR pseudogene 1 | 0.716 | 0.269 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2015 | 2017 | |||||||||
|
insulin like growth factor 2 mRNA binding protein 1 | 0.560 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
lysyl oxidase | 0.447 | 0.846 | 0.99 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
calcium responsive transcription factor | 0.769 | 0.269 | 8.0E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
component of oligomeric golgi complex 5 | 0.656 | 0.538 | 9.8E-20 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2017 | 2018 | |||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.180 | None | 1.000 | 4 | 2 | 1998 | 2018 | ||||||||
|
TCF21 antisense RNA inducing promoter demethylation | 0.821 | 0.308 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2015 | 2018 | |||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.110 | None | 1.000 | 4 | 1 | 2015 | 2018 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 2 | 0.656 | 0.577 | 1.00 |
|
disease | 0.140 | None | 1.000 | 4 | 3 | 2008 | 2018 | ||||||||
|
mortality factor 4 like 1 | 0.736 | 0.423 | 0.99 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2013 | 2018 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
switching B cell complex subunit SWAP70 | 0.736 | 0.385 | 5.0E-02 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2018 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.140 | None | 0.875 | 3 | 3 | 2010 | 2018 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2013 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.200 | None | 0.833 | 3 | 5 | 1996 | 2018 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2017 | 2018 |